OncLive | Challenges Still Abound in Antibody Therapeutics OncLive The laboratory program that Andrew Scott, MB,BS, MD, heads at the Ludwig Institute for Cancer Research in Australia is focused on the development of recombinant antibodies for diagnostic and therapeutic application in tumors. Its work has led to the ... |
